Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
In October 2018, the use of recreational cannabis was legalized across Canada. Looking back at the past year, physicians remain divided in their views towards this new legislation, though support skews towards younger GPs. This legislation has impacted the use of prescription treatments and patient visits in a number of key therapeutic areas, though not to the degree that was anticipated 12 months ago.
Over a 3-day period, MD Analytics surveyed 1,000 Canadians that are responsible for making health-related decisions. It was found that respondents are often choosing to not to see a physician when health-related scenarios arise, citing self-diagnosis or lack of convenience as their key reasons. Respondents are also strongly likely to visit a walk-in clinic instead of their family physician, with convenience again mentioned as the key reason.
The Canadian Senate recently passed Bill C-46 which will allow for the legal use of recreational cannabis across Canada by Fall 2018. While some physicians anticipate this new legislation will impact their practices with patients electing to try recreational cannabis instead of more traditional prescription medications or medical cannabis, others anticipate increases in patient visits related to dependence and psychotic symptoms.
With the emergence of Complementary and Alternative Medicine (CAM), prescription options alone are no longer the norm as it pertains to treating a number of medical conditions. Research among 170 Canadian physicians shows that CAM therapies are not only common practice for many already, but are expected to become even more widely accepted as viable treatment options within the conventional medical community.
Modern Blood Glucose Meter (BGM) devices can often pair with a companion app on a smartphone, which allows patients to easily record and monitor their blood glucose levels over time. This gives the patient, and potentially their doctor, easy to access historical data, insightful charts, and other information that can aid in diabetes management. Research was conducted by MD Analytics to assess whether Canadian GPs are accepting this technology, and if it plays a role in their recommendation of one BGM over another.